Cat. #152670
Anti-hnRNP-K (isoform1) [N10 P2D3*G2]
Cat. #: 152670
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Heterogeneous nuclear ribonucleoprotein K isoform 1, hnRNP-K, hnRNPK
Class: Monoclonal
Application: IHC ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Ayham Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-hnRNP-K (isoform1) [N10 P2D3*G2]
- Research fields: Cell biology;Genetics
- Clone: N10 P2D3*G2
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 51 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IHC ; WB
- Description: The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a nucleic acid-binding protein that serves as a docking platform integrating transduction pathways to nucleic acid-directed processes. This protein has recently emerged as an important player in carcinogenesis process. HnRNP K is overexpressed in several human cancers and its aberrant cytoplasmic localization has been associated with a worse prognosis for patients, suggesting that it has a role in cancer progression.
- Immunogen: Ovalbumin-conjugated synthetic peptide SVKQYSGKFF (C-terminal sequence)
- Isotype: IgG1 kappa
- Recommended controls: IHC - formalin-fixed, paraffin-embedded colorectal cancer sections; WB - Jurkat cell lysate
Target Details
- Target: Heterogeneous nuclear ribonucleoprotein K isoform 1, hnRNP-K, hnRNPK
- Molecular weight: 51 kDa
- Tissue cell line specificity: IHC - formalin-fixed, paraffin-embedded colorectal cancer sections; WB - Jurkat cell lysate
- Target background: The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a nucleic acid-binding protein that serves as a docking platform integrating transduction pathways to nucleic acid-directed processes. This protein has recently emerged as an important player in carcinogenesis process. HnRNP K is overexpressed in several human cancers and its aberrant cytoplasmic localization has been associated with a worse prognosis for patients, suggesting that it has a role in cancer progression.
Applications
- Application: IHC ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C